97 related articles for article (PubMed ID: 14567792)
1. Data concordance from a comparison between filter binding and fluorescence polarization assay formats for identification of ROCK-II inhibitors.
Hubert CL; Sherling SE; Johnston PA; Stancato LF
J Biomol Screen; 2003 Aug; 8(4):399-409. PubMed ID: 14567792
[TBL] [Abstract][Full Text] [Related]
2. Quantitative high-throughput cell-based assays for inhibitors of ROCK kinases.
Garton AJ; Castaldo L; Pachter JA
Methods Enzymol; 2008; 439():491-500. PubMed ID: 18374184
[TBL] [Abstract][Full Text] [Related]
3. Rho family-associated kinases PAK1 and rock.
Maruta H; Nheu TV; He H; Hirokawa Y
Prog Cell Cycle Res; 2003; 5():203-10. PubMed ID: 14593714
[TBL] [Abstract][Full Text] [Related]
4. Comparison of miniaturized time-resolved fluorescence resonance energy transfer and enzyme-coupled luciferase high-throughput screening assays to discover inhibitors of Rho-kinase II (ROCK-II).
Schröter T; Minond D; Weiser A; Dao C; Habel J; Spicer T; Chase P; Baillargeon P; Scampavia L; Schürer S; Chung C; Mader C; Southern M; Tsinoremas N; LoGrasso P; Hodder P
J Biomol Screen; 2008 Jan; 13(1):17-28. PubMed ID: 18227223
[TBL] [Abstract][Full Text] [Related]
5. Phosphoryl transfer is not rate-limiting for the ROCK I-catalyzed kinase reaction.
Futer O; Saadat AR; Doran JD; Raybuck SA; Pazhanisamy S
Biochemistry; 2006 Jun; 45(25):7913-23. PubMed ID: 16784244
[TBL] [Abstract][Full Text] [Related]
6. Assay development and screening of a serine/threonine kinase in an on-chip mode using caliper nanofluidics technology.
Perrin D; Frémaux C; Scheer A
J Biomol Screen; 2006 Jun; 11(4):359-68. PubMed ID: 16751332
[TBL] [Abstract][Full Text] [Related]
7. Rho and ROCK signaling in VEGF-induced microvascular endothelial hyperpermeability.
Sun H; Breslin JW; Zhu J; Yuan SY; Wu MH
Microcirculation; 2006; 13(3):237-47. PubMed ID: 16627366
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of Rho-kinase modulate amyloid-beta (Abeta) secretion but lack selectivity for Abeta42.
Leuchtenberger S; Kummer MP; Kukar T; Czirr E; Teusch N; Sagi SA; Berdeaux R; Pietrzik CU; Ladd TB; Golde TE; Koo EH; Weggen S
J Neurochem; 2006 Jan; 96(2):355-65. PubMed ID: 16300630
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a competitive AKT serine/threonine kinase fluorescence polarization assay using a product-specific anti-phospho-serine antibody.
Turek TC; Small EC; Bryant RW; Hill WA
Anal Biochem; 2001 Dec; 299(1):45-53. PubMed ID: 11726183
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases.
Ishizaki T; Uehata M; Tamechika I; Keel J; Nonomura K; Maekawa M; Narumiya S
Mol Pharmacol; 2000 May; 57(5):976-83. PubMed ID: 10779382
[TBL] [Abstract][Full Text] [Related]
11. Development of a microplate-based, electrophoretic fluorescent protein kinase a assay: comparison with filter-binding and fluorescence polarization assay formats.
Miick SM; Jalali S; Dwyer BP; Havens J; Thomas D; Jimenez MA; Simpson MT; Zile B; Huss KL; Campbell RM
J Biomol Screen; 2005 Jun; 10(4):329-38. PubMed ID: 15964934
[TBL] [Abstract][Full Text] [Related]
12. Organized migration of epithelial cells requires control of adhesion and protrusion through Rho kinase effectors.
Hopkins AM; Pineda AA; Winfree LM; Brown GT; Laukoetter MG; Nusrat A
Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G806-17. PubMed ID: 17138966
[TBL] [Abstract][Full Text] [Related]
13. Development of a 1-microl scale assay for mitogen-activated kinase kinase 7 using 2-D fluorescence intensity distribution analysis anisotropy.
Wright PA; Boyd HF; Bethell RC; Busch M; Gribbon P; Kraemer J; Lopez-Calle E; Mander TH; Winkler D; Benson N
J Biomol Screen; 2002 Oct; 7(5):419-28. PubMed ID: 14599357
[TBL] [Abstract][Full Text] [Related]
14. Miniaturization and validation of a high-throughput serine kinase assay using the AlphaScreen platform.
Von Leoprechting A; Kumpf R; Menzel S; Reulle D; Griebel R; Valler MJ; Büttner FH
J Biomol Screen; 2004 Dec; 9(8):719-25. PubMed ID: 15634799
[TBL] [Abstract][Full Text] [Related]
15. Screening for cell migration inhibitors via automated microscopy reveals a Rho-kinase inhibitor.
Yarrow JC; Totsukawa G; Charras GT; Mitchison TJ
Chem Biol; 2005 Mar; 12(3):385-95. PubMed ID: 15797222
[TBL] [Abstract][Full Text] [Related]
16. A homogeneous fluorescence polarization assay adaptable for a range of protein serine/threonine and tyrosine kinases.
Gaudet EA; Huang KS; Zhang Y; Huang W; Mark D; Sportsman JR
J Biomol Screen; 2003 Apr; 8(2):164-75. PubMed ID: 12844437
[TBL] [Abstract][Full Text] [Related]
17. A Rho-associated protein kinase: differentially distributed in limbal and corneal epithelia.
SundarRaj N; Kinchington PR; Wessel H; Goldblatt B; Hassell J; Vergnes JP; Anderson SC
Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1266-72. PubMed ID: 9620089
[TBL] [Abstract][Full Text] [Related]
18. Rho A/Rho kinase mRNA and protein levels in human myometrium during pregnancy and labor.
Friel AM; Curley M; Ravikumar N; Smith TJ; Morrison JJ
J Soc Gynecol Investig; 2005 Jan; 12(1):20-7. PubMed ID: 15629666
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of ROCK by RhoE.
Riento K; Ridley AJ
Methods Enzymol; 2006; 406():533-41. PubMed ID: 16472685
[TBL] [Abstract][Full Text] [Related]
20. Rho and Rho-kinase (ROCK) signaling in adherens and gap junction assembly in corneal epithelium.
Anderson SC; Stone C; Tkach L; SundarRaj N
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):978-86. PubMed ID: 11923237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
